Shine Medical Technology is raising another $30 million as it expands its capability for the production of Moly-99 for generator production. The company has secured major funding from several sources and continues to grow. It expects to begin production in 2021 with commercial product being ready in 2022. All good news for the Nuclear Medicine clinical marketplace.